Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy (HYPER)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2011 by University Hospital Birmingham.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
University of Birmingham
Brighton and Sussex University Hospitals NHS Trust
British Heart Foundation
Information provided by:
University Hospital Birmingham
ClinicalTrials.gov Identifier:
NCT00989508
First received: October 2, 2009
Last updated: August 10, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)